All Stories

  1. Familial associations between ANCA-associated vasculitis and other immune-mediated inflammatory diseases: a case control study
  2. Low dose IL-2 administration prevents but fails to treat experimental autoimmune anti-myeloperoxidase glomerulonephritis
  3. Both Classical and Non-Classical Monocytes Patrol Glomerular Capillaries and Promote Acute Glomerular Inflammation
  4. Relationships between patient and physician global assessments in anti-neutrophil cytoplasmic antibody-associated vasculitis
  5. Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis
  6. The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus
  7. Challenges for trainee physician–scientists during their PhD candidature: a cross‐sectional study
  8. Variation in approaches to acute ANCA‐associated vasculitis in Australia and New Zealand: rituximab, plasma exchange and glucocorticoids
  9. Hematuria in Podocytopathies
  10. The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases
  11. The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC)
  12. Glomerulonephritis: immunopathogenesis and immunotherapy
  13. Toll-like Receptor 9 Induced Dendritic Cell Activation Promotes Anti-Myeloperoxidase Autoimmunity and Glomerulonephritis
  14. T‐cell receptor αβ+ double‐negative T cells in the kidney are predominantly extravascular and increase in abundance in response to ischemia–reperfusion injury
  15. Identifying Antigen-Specific T Cells in ANCA-Associated Vasculitis: A Glimpse of the Future?
  16. Immunoaging within the kidney via injury-associated tertiary lymphoid tissue
  17. Case of vertebral fracture with nephrolithiasis and hypocitraturia
  18. Tetraspanin CD53 modulates lymphocyte trafficking but not systemic autoimmunity in Lyn‐deficient mice
  19. Immune cell behaviour and dynamics in the kidney — insights from in vivo imaging
  20. Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis
  21. The impact of antineutrophil cytoplasmic antibody‐associated vasculitis on employment and work disability in an Australian population
  22. Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
  23. Anti-CD20 mAb-Induced B Cell Apoptosis Generates T Cell Regulation of Experimental Myeloperoxidase ANCA-Associated Vasculitis
  24. ANCA-associated vasculitis
  25. Experimental Antiglomerular Basement Membrane GN Induced by a Peptide from Actinomyces
  26. Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers
  27. A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity
  28. Apoptotic Cell–Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN
  29. Standardized Outcomes in Nephrology—Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease
  30. Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus
  31. HLA-DR15-specific inhibition attenuates autoreactivity to the Goodpasture antigen
  32. The renal draining lymph nodes in acute inflammatory kidney disease
  33. Platelet retention in inflamed glomeruli occurs via selective prolongation of interactions with immune cells
  34. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
  35. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
  36. Intrarenal Toll-like receptor 4 and Toll-like receptor 2 expression correlates with injury in antineutrophil cytoplasmic antibody-associated vasculitis
  37. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus
  38. Goodpasture's autoimmune disease — A collagen IV disorder
  39. Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus
  40. HLA and kidney disease: from associations to mechanisms
  41. Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis
  42. CD8+ cells and glomerular crescent formation: outside-in as well as inside-out
  43. Chimeric antigen receptor T (CAR T) cells: another cancer therapy with potential applications in kidney disease and transplantation?
  44. OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis
  45. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis
  46. Effector CD4+ T cells recognize intravascular antigen presented by patrolling monocytes
  47. The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis
  48. Regulatory T cells in renal disease
  49. Inflammasomes in the Kidney
  50. Immune-mediated kidney disease in 2017: Progress in mechanisms and therapy for immunological kidney disease
  51. Renal Dendritic Cells: The Long and Winding Road
  52. Pathogenic Role for γδ T Cells in Autoimmune Anti-Myeloperoxidase Glomerulonephritis
  53. ANCA-Associated Vasculitis: Pathogenesis, Models, and Preclinical Testing
  54. Chyluria: When is proteinuria ‘not proteinuria’?
  55. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells
  56. Activated Renal Dendritic Cells Cross Present Intrarenal Antigens After Ischemia-Reperfusion Injury
  57. Imaging Leukocyte Responses in the Kidney
  58. In Vivo Imaging of Inflamed Glomeruli Reveals Dynamics of Neutrophil Extracellular Trap Formation in Glomerular Capillaries
  59. Interleukin-17RA Promotes Humoral Responses and Glomerular Injury in Experimental Rapidly Progressive Glomerulonephritis
  60. From bench to pet shop to bedside? The environment and immune function in mice
  61. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis
  62. The NLRP3 inflammasome in kidney disease and autoimmunity
  63. Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus
  64. CD8 + T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN
  65. The Players: Cells Involved in Glomerular Disease
  66. Erratum: Corrigendum: Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus
  67. Biologics for the treatment of autoimmune renal diseases
  68. Regulatory T cells in immune-mediated renal disease
  69. Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase
  70. Can we target IL-17A and IL-23 in immune kidney disease?
  71. Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis
  72. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis
  73. Mast Cell Stabilization Ameliorates Autoimmune Anti-Myeloperoxidase Glomerulonephritis
  74. Endogenous Toll-Like Receptor 9 Regulates AKI by Promoting Regulatory T Cell Recruitment
  75. Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase
  76. Myeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GN
  77. Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  78. FMS-Like Tyrosine Kinase 3 Ligand Treatment Does Not Ameliorate Experimental Rapidly Progressive Glomerulonephritis
  79. CX3CR1 Reduces Kidney Fibrosis by Inhibiting Local Proliferation of Profibrotic Macrophages
  80. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis
  81. T Cell Mediated Autoimmune Glomerular Disease in Mice
  82. Regulatory T Cells Dynamically Regulate Selectin Ligand Function during Multiple Challenge Contact Hypersensitivity
  83. Four pediatric patients with autosomal recessive polycystic kidney disease developed new-onset diabetes after renal transplantation
  84. Glomerulonephritis Induced by Heterologous Anti-GBM Globulin as a Planted Foreign Antigen
  85. Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes
  86. Omeprazole-induced acute interstitial nephritis: A possible Th1-Th17-mediated injury?
  87. Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Faslpr mice
  88. Innate IL-17A–Producing Leukocytes Promote Acute Kidney Injury via Inflammasome and Toll-Like Receptor Activation
  89. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane
  90. Dendritic cells in progressive renal disease: some answers, many questions
  91. Histopathologic and Clinical Predictors of Kidney Outcomes in ANCA-Associated Vasculitis
  92. Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function
  93. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis
  94. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis
  95. The HLA-DRB1*15:01-Restricted Goodpasture's T Cell Epitope Induces GN
  96. Thymic Deletion and Regulatory T Cells Prevent Antimyeloperoxidase GN
  97. Proteolysis Breaks Tolerance toward Intact  345(IV) Collagen, Eliciting Novel Anti-Glomerular Basement Membrane Autoantibodies Specific for  345NC1 Hexamers
  98. Deficiency of Annexin A1 in CD4+ T Cells Exacerbates T Cell-Dependent Inflammation
  99. Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus
  100. Mast Cells Contribute to Peripheral Tolerance and Attenuate Autoimmune Vasculitis
  101. CD4+ Th1 cells are effectors in lupus nephritis—but what are their targets?
  102. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis
  103. Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction
  104. Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis
  105. Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells
  106. Endogenous Regulatory T Cells Adhere in Inflamed Dermal Vessels via ICAM-1: Association with Regulation of Effector Leukocyte Adhesion
  107. Renal Dendritic Cells Adopt a Pro-Inflammatory Phenotype in Obstructive Uropathy to Activate T Cells but Do Not Directly Contribute to Fibrosis
  108. Tim-1 promotes cisplatin nephrotoxicity
  109. Mast Cells Mediate Acute Kidney Injury through the Production of TNF
  110. Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis
  111. Interleukin-17A Promotes Early but Attenuates Established Disease in Crescentic Glomerulonephritis in Mice
  112. Endogenous foxp3+ T-regulatory cells suppress anti-glomerular basement membrane nephritis
  113. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis
  114. The IL-27 Receptor Has Biphasic Effects in Crescentic Glomerulonephritis Mediated Through Th1 Responses
  115. The Emergence of Th17 Cells as Effectors of Renal Injury
  116. The Th17-Defining Transcription Factor ROR t Promotes Glomerulonephritis
  117. Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis
  118. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy
  119. Toll-Like Receptor 9 Enhances Nephritogenic Immunity and Glomerular Leukocyte Recruitment, Exacerbating Experimental Crescentic Glomerulonephritis
  120. Platelet Recruitment to the Inflamed Glomerulus Occurs via an αIIbβ3/GPVI-Dependent Pathway
  121. Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM Nephritis
  122. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
  123. Review Article: Review: T helper 17 cells: Their role in glomerulonephritis
  124. Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis
  125. Corrigendum
  126. Th1 and Th17 Cells Induce Proliferative Glomerulonephritis
  127. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis
  128. Review article: Kidney dendritic cells: Their role in homeostasis, inflammation and transplantation
  129. Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis
  130. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis
  131. Antimyeloperoxidase antibodies rapidly induce  4-integrin-dependent glomerular neutrophil adhesion
  132. IL-23, not IL-12, Directs Autoimmunity to the Goodpasture Antigen
  133. Kidney Research
  134. Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney
  135. Advances in the pathogenesis of Goodpasture's disease: From epitopes to autoantibodies to effector T cells
  136. The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response
  137. Targeting Leukocytes in Immune Glomerular Diseases
  138. The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity
  139. Intrarenal Antigens Activate CD4+ Cells via Co-stimulatory Signals from Dendritic Cells
  140. T-bet Deficiency Attenuates Renal Injury in Experimental Crescentic Glomerulonephritis
  141. A New Approach to Idiopathic Nephrotic Syndrome
  142. Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease
  143. Methods in Renal Research: A new section in Nephrology (Editorial)
  144. Endogenous Myeloperoxidase Promotes Neutrophil-Mediated Renal Injury, but Attenuates T Cell Immunity Inducing Crescentic Glomerulonephritis
  145. Chapter 3 Pathogenesis of Renal Disease: Cytokines and Other Soluble Factors
  146. CD100 Enhances Dendritic Cell and CD4+ Cell Activation Leading to Pathogenetic Humoral Responses and Immune Complex Glomerulonephritis
  147. Anti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis
  148. Inducible Co-Stimulatory Molecule Ligand Is Protective during the Induction and Effector Phases of Crescentic Glomerulonephritis
  149. IL-18 is redundant in T-cell responses and in joint inflammation in antigen-induced arthritis
  150. The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease
  151. A Pathogenetic Role for Mast Cells in Experimental Crescentic Glomerulonephritis
  152. 'Genetics and The Immune Response' Abstracts of the 35th Annual Scientific Meeting of the Australasian Society for Immunology and 14th International HLA & Immunogenetics Workshop
  153. Glomerulonephritis, Th1 and Th2: what's new?
  154. More Targeted Treatments for Lupus Nephritis: Is the Future (Nearly) Here?
  155. CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms
  156. Granulocyte Macrophage Colony-Stimulating Factor Expression by Both Renal Parenchymal and Immune Cells Mediates Murine Crescentic Glomerulonephritis
  157. Glomerular Expression of CD80 and CD86 Is Required for Leukocyte Accumulation and Injury in Crescentic Glomerulonephritis
  158. IL-12p40 and IL-18 in Crescentic Glomerulonephritis: IL-12p40 is the Key Th1-Defining Cytokine Chain, Whereas IL-18 Promotes Local Inflammation and Leukocyte Recruitment
  159. Experimental autoimmune Goodpasture's disease: A pathogenetic role for both effector cells and antibody in injury
  160. Endogenous IL-13 Limits Humoral Responses and Injury in Experimental Glomerulonephritis but Does Not Regulate Th1 Cell-Mediated Crescentic Glomerulonephritis
  161. Fibrin independent proinflammatory effects of tissuefactor in experimental crescentic glomerulonephritis
  162. Experimental Autoimmune Anti-Glomerular Basement Membrane Glomerulonephritis: A Protective Role for IFN- 
  163. Plasmin is not protective in experimental renal interstitial fibrosis1
  164. Contributions of IL-1  and IL-1  to Crescentic Glomerulonephritis in Mice
  165. The role of flow cytometric ANCA detection in screening for acute pauci-immune crescentic glomerulonephritis
  166. Intrinsic Renal Cell Expression of CD40 Directs Th1 Effectors Inducing Experimental Crescentic Glomerulonephritis
  167. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis
  168. Plasminogen Activator Inhibitor-1 Is a Significant Determinant of Renal Injury in Experimental Crescentic Glomerulonephritis
  169. Cytokines, T cells and proliferative glomerulonephritis
  170. Effects of CTLA4-Fc on glomerular injury in humorally-mediated glomerulonephritis in BALB/c mice
  171. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis
  172. Oxidant stress is increased within the glomerulus in experimental diabetic nephropathy
  173. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis
  174. Chemokines as therapeutic targets in renal disease
  175. Immunopathogenesis of crescentic glomerulonephritis
  176. Th1 and Th2T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis
  177. IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis
  178. Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice
  179. Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis
  180. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis